CNBX PHARMACEUTICAL INC by CNBX Pharmaceuticals Inc. (CNBX) Stock Price, Quote, News & History

Key Statistics

Open

$0.00

Volume / Avg.

1.60M / 14.81M

Day Range

$0.00 - $0.00

52 Wk Range

0.00 - 0.00

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent CNBX Pharmaceuticals Inc News

CNBX Acquires A Controlling Interest In Cancer Immunotherapy Developer

CNBX Pharmaceuticals Inc. (OTCQB: CNBX) has acquired a controlling interest in TaGeza Biopharmaceuticals Ltd. The TaGeza research team remains committed to the company, and co-founder professor Benjamin Dekel (MD, PhD) will continue to serve as the company's chief scient

Vuk Zdinjak

Cannabics Pharmaceuticals Changes Name To CNBX Pharmaceuticals, Moves Ahead With Cancer Treatment Drug Research

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) has changed its corporate name to "CNBX Pharmaceuticals Inc."

Vuk Zdinjak

Cannabics Pharmaceuticals Announces Two New Provisional Patents: Compositions and Methods For Treating Cancer

Cannabics Pharmaceuticals Inc.

Maureen Meehan

Marijuana Stock Movers For October 8, 2021

GAINERS: Leviathan Natural Prods (OTC:LVCNF) shares closed up 14.86% at $0.52 with an estimated market cap of $43.9M.

Jose Rodrigo Safdiye

Bullish Sentiment For Marijuana Stocks: Tilray, GrowGeneration & Canopy Growth Among Top Cannabis Movers For October 7, 2021

GAINERS: Charlottes Web Holdings (OTC:CWBHF) shares closed up 21.59% at $2.14 with an estimated market cap of $271.7M.

Jose Rodrigo Safdiye

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-154.17K

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

150.01K

Free Cash Flow (TTM)

-154.17K

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-4.16K

Valuation Metrics

Enterprise Value

$1.32M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

0.00%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

-$0.00

Company Debt

Total Debt

$1.17M

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$9.49K

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$0.00

Volume / Avg.

1.60M / 14.81M

Day Range

$0.00 - $0.00

52 Wk Range

0.00 - 0.00

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Pharmaceuticals

CNBX Pharmaceuticals Inc is a clinical-stage biotechnology company. It develops pharmaceuticals focusing on cancer research utilizing HTS technology and personalized bioinformatics tools. The company's main focus is the development of cannabinoid the...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

CNBX

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

CNBX

FAQ

How do I buy CNBX PHARMACEUTICAL INC by CNBX Pharmaceuticals Inc. (CNBX) stock?

You can purchase shares of CNBX PHARMACEUTICAL INC by CNBX Pharmaceuticals Inc. (OTCID:CNBX) through any online brokerage.

View our list of the best stock brokerages

Who are CNBX PHARMACEUTICAL INC by CNBX Pharmaceuticals Inc. (CNBX) competitors?

There are no as such competitors for CNBX PHARMACEUTICAL INC by CNBX Pharmaceuticals Inc..

What is the forecast, or price target, for CNBX PHARMACEUTICAL INC by CNBX Pharmaceuticals Inc. (CNBX) stock?

There is no analysis for CNBX PHARMACEUTICAL INC by CNBX Pharmaceuticals Inc. to provide a consensus price target.

What is the current price for CNBX PHARMACEUTICAL INC by CNBX Pharmaceuticals Inc. (CNBX)?

The stock price for CNBX PHARMACEUTICAL INC by CNBX Pharmaceuticals Inc. (OTCID: CNBX) is $0.0001 last updated September 10, 2026 at 3:30 PM EDT.

Does CNBX PHARMACEUTICAL INC by CNBX Pharmaceuticals Inc. (CNBX) pay a dividend?

There are no upcoming dividends for CNBX PHARMACEUTICAL INC by CNBX Pharmaceuticals Inc..

When is CNBX PHARMACEUTICAL INC by CNBX Pharmaceuticals Inc. (OTCID:CNBX) reporting earnings?

CNBX PHARMACEUTICAL INC by CNBX Pharmaceuticals Inc. does not have any upcoming earnings scheduled.

Is CNBX PHARMACEUTICAL INC by CNBX Pharmaceuticals Inc. (CNBX) going to split?

There is no upcoming split for CNBX PHARMACEUTICAL INC by CNBX Pharmaceuticals Inc..

What sector and industry does CNBX PHARMACEUTICAL INC by CNBX Pharmaceuticals Inc. (CNBX) operate in?

CNBX PHARMACEUTICAL INC by CNBX Pharmaceuticals Inc. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCID.